Abstract
Serum β2-microglubin (β2-m) levels were measured in oral carcinoma patients and compared with normal healthy controls. It was observed that there was a significant rise in serum β2-microglobulin in oral carcinoma patients. Progressively higher values were obtained as the cancer advanced clinically. Therefore the estimation of serum β2-microglobulin may be useful as one of a battery of tests in the assessment of oral carcinoma patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berggard, I. and Bearn, A.G. (1968). Isolation and properties of a low molecular weight β2-globulin occurring in human biological fluids. J. Biol. Chem. 243, 4095–4103.
Child, J.A., Spati, B., Illingworth, S., Barnard, D., Corbett, S., Simmons, A.V., Stone, J., Worthy, T.S. and Cooper, E.H. (1980) Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas. Cancer. 45, 318–326.
Anil, S., Beena, V.T., Nair, R.G. and Vijayakumar, T. (1994) Evaluation of serum β2-micr in premalignant and malignant lesions of the oral cavity. Oral. Surg. Oral. Med. Oral. Pathol. 79, 750–752.
Scully, C. (1981) Serum β2-microglobulin in oral malignancy and premalignancy. J. Oral. Pathol. 10, 354–357.
Vinzenz, K., Schonthal, E., Zekert, F. and Wunderer, S. (1987) Diagnosis of head and neck carcinomas by means of immunological tumour markers. J. Cranio. Max. Fac. Surg. 15, 270–277.
Beta 2-microglobulin EIA kit, Immunotech, France, booklet on directions for use.
Shuster, J., Gold, P. and Poulik, M.D. (1976) β2-microglobulin levels in cancerous and other disease states. Clin. Chim. Acta. 67, 307–313.
Evrin, P.E. and Wibell, L. (1973) Serum β2-microglobulin in various disorders. Clin. Chim. Acta. 43, 183–187.
Kithier, K., Cejka, J., Belamariac, J., Al-Sarraf, M., Peterson, W.D., Vaitkevicius, V.K. and Poulik, M.D. (1974) β2-microglobulin: Occurrence in fetal life and malignancy. Clin. Chim. Acta. 52, 293–299.
Miyata, T., Jadoul, M., Kurokawa, K. and Strihou, C.V.Y. (1998) Beta-2 microglobulin in renal disease. J. Am. Soc. Nephrol. 9, 1723–1735.
Eley, B.S., Hughes, J., Potgieter, S., Keraan, M., Burgess, J. and Hussey, G.D. (1999) Immunological manifestations of HIV-infected children. Ann. Trop. Paediatr. 19: 3–7.
De Pita, O., Frezzolini, A., Cianetti, A., De Sanctis, G., Fontana, L. and Bottari, V. (1999) Squamous cell carcinoma related antigen (SCCr-Ag), sICAM-1 and beta 2-microglobulin are useful markers of disease activity in psoriasis. Acta. Derm. Venereol. 79, 132–135.
Morra, E. (1999) The biological markers of non-Hodgkin's lymphomas: their role in diagnosis, prognostic assessment and therapeutic strategy. Int. J. Biol. Markers. 14, 149–153.
Rodriguez, J., Cortes, J., Talpaz, M., O'Brien, S., Smith, T.L., Rios, M.B. and Kantarjian, H. (2000) Serum β2-microglobulin levels are a significant prognostic factor in philadelphia chromosome—positive chronic myelogenous leukemia. Clin. Cancer. Res. 6, 147–152.
Amlot, P.L. and Adinolfi, M. (1979) Serum β2-microglobulin and its prognostic value in lymphomas. Eur. J. Cancer. 15, 791–796.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Silvia, C.R.W.D., Vasudevan, D.M. & Prabhu, K.S. Alteration of serum beta 2-microglobulin in oral carcinoma. Indian J Clin Biochem 17, 104–107 (2002). https://doi.org/10.1007/BF02867981
Issue Date:
DOI: https://doi.org/10.1007/BF02867981